Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis
Open Access
- 27 June 2025
- journal article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 77 (10) , 1442-1450
Abstract
Objective: Systemic juvenile idiopathic arthritis (sJIA) is a chronic childhood disease classically attributed to innate immune cell dysregulation. This study aimed to elucidate the role of innate lymphoid cells (ILCs), including natural killer (NK) cells and helper‐ILCs (hILCs), in sJIA during clinically inactive disease (CID) through phenotypic and functional analysis.Methods: Peripheral ILCs from children with sJIA during CID receiving interleukin‐1 (IL‐1) inhibitors (n = 40) were analyzed by flow cytometry and compared to 23 healthy children (HC) and 22 patients with unrelated autoinflammatory diseases taking IL‐1 inhibitors. Plasma proteomic profiling was also performed.Results: Patients with sJIA showed a significant reduction in circulating NK cell frequencies compared to HC, with an increased proportion of CD56bright NK cells. Although overall hILC frequencies were comparable to HC, ILC1s were increased, whereas ILC precursors were reduced. ILC1 frequency correlated positively with IL‐18 plasma levels, whereas ILC2 frequency correlated negatively. Functional assessments revealed that NK cells from patients with sJIA had variable interferon γ (IFNγ) production upon IL‐18/IL‐12 stimulation, inversely correlating with IL‐18 levels. Additionally, hILCs from these patients showed a specific impairment in IFNγ production despite normal IL‐13 production, potentially linked to decreased IL‐18 receptor α expression in ILC1s. Proteomic analysis confirmed IL‐18 as the most up‐regulated cytokine in sJIA plasma.Conclusion: Patients with sJIA in CID exhibit significant innate immune abnormalities, including altered ILC subset distribution and impaired IFNγ production, strongly associated with IL‐18 levels. These findings suggest ongoing immune dysregulation despite clinical remission, underscoring a potential role for ILCs and cytokine interaction in sJIA pathogenesis.Keywords
Funding Information
- Ministero della Salute
- Fondazione Umberto Veronesi
- Fondazione AIRC per la ricerca sul cancro ETS (27022)
This publication has 17 references indexed in Scilit:
- Multi-modal immune dynamics of pre-COVID-19 Kawasaki Disease following intravenous immunoglobulinClinical Immunology, 2024
- Treatment of systemic juvenile idiopathic arthritisNature Reviews Rheumatology, 2023
- Human NK cells, their receptors and functionEuropean Journal of Immunology, 2021
- Innate Lymphoid Cells and T Cells Contribute to the Interleukin‐17A Signature Detected in the Synovial Fluid of Patients With Juvenile Idiopathic ArthritisArthritis & Rheumatology, 2019
- Innate Lymphoid Cells: 10 Years OnCell, 2018
- A multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritisJournal of Experimental Medicine, 2017
- Systemic Human ILC Precursors Provide a Substrate for Tissue ILC DifferentiationCell, 2017
- Inflammatory Gene Expression Profile and Defective Interferon‐γ and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis PatientsArthritis & Rheumatology, 2016
- Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questionsNature Reviews Rheumatology, 2011
- Defective phosphorylation of interleukin‐18 receptor β causes impaired natural killer cell function in systemic‐onset juvenile idiopathic arthritisArthritis & Rheumatism, 2009